LSL Pharma Group, Inc.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 86.36% vs 57.14% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is -1,300.00% vs 33.33% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "12.30",
          "val2": "6.60",
          "chgp": "86.36%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-1.00",
          "val2": "0.90",
          "chgp": "-211.11%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.00",
          "val2": "0.60",
          "chgp": "66.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-2.80",
          "val2": "-0.20",
          "chgp": "-1,300.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-149.20%",
          "val2": "65.40%",
          "chgp": "-21.46%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 62.15% vs 77.00% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -184.85% vs 138.82% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "28.70",
          "val2": "17.70",
          "chgp": "62.15%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.20",
          "val2": "1.90",
          "chgp": "-89.47%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "2.90",
          "val2": "1.90",
          "chgp": "52.63%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.10",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-2.80",
          "val2": "3.30",
          "chgp": "-184.85%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-80.40%",
          "val2": "22.90%",
          "chgp": "-10.33%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY

Mar'26

Mar'25

Change(%)

Net Sales

12.30

6.60

86.36%

Operating Profit (PBDIT) excl Other Income

-1.00

0.90

-211.11%

Interest

1.00

0.60

66.67%

Exceptional Items

0.00

0.00

Consolidate Net Profit

-2.80

-0.20

-1,300.00%

Operating Profit Margin (Excl OI)

-149.20%

65.40%

-21.46%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Mar 2026 is 86.36% vs 57.14% in Mar 2025

Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is -1,300.00% vs 33.33% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

28.70

17.70

62.15%

Operating Profit (PBDIT) excl Other Income

0.20

1.90

-89.47%

Interest

2.90

1.90

52.63%

Exceptional Items

-0.10

0.00

Consolidate Net Profit

-2.80

3.30

-184.85%

Operating Profit Margin (Excl OI)

-80.40%

22.90%

-10.33%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 62.15% vs 77.00% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -184.85% vs 138.82% in Dec 2024

All Annual Results